News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Fitzpatrick Mark J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2020 |
4
| Fitzpatrick Mark J. (President) has filed a Form 4 on CHIASMA, INC|
Txns:
| Exercised 10,000 options to buy
@ $2.6, valued at
$26k
|
|
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2018 |
4
| Fitzpatrick Mark J. (President and CEO) has filed a Form 4 on CHIASMA, INC|
Txns:
| Bought 9,612 shares
@ $2.5, valued at
$24k
|
|
| 02/26/2018 |
4
| Fitzpatrick Mark J. (President and CEO) has filed a Form 4 on CHIASMA, INC|
Txns:
| Granted 194,183 options to buy
@ $1.52, valued at
$295.2k
Granted 67,967 options to buy
@ $1.52, valued at
$103.3k
|
|
| 10/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/03/2015 |
4
| Fitzpatrick Mark J. (CFO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0
Granted 10,000 options to buy
@ $0 |
|
| 01/05/2015 |
4
| Fitzpatrick Mark J. (CFO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Granted 65,000 options to buy
@ $15.95, valued at
$1M
|
|
| 08/20/2014 |
4
| Fitzpatrick Mark J. (CFO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Bought 1,150 shares
@ $30.64, valued at
$35.2k
|
|
| 04/21/2014 |
4
| Fitzpatrick Mark J. (CFO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0 |
|
| 03/05/2014 |
4
| Fitzpatrick Mark J. (CFO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Exercised 2,500 options to buy
@ $17.64, valued at
$44.1k
|
|
| 02/12/2014 |
4
| Fitzpatrick Mark J. (CFO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Sold 3,300 shares
@ $61.71, valued at
$203.6k
Sold 2,814 shares
@ $62.94, valued at
$177.1k
Sold 900 shares
@ $63.72, valued at
$57.3k
Sold 486 shares
@ $64.69, valued at
$31.4k
Exercised 7,500 options to buy
@ $17.64, valued at
$132.3k
|
|
| 11/13/2013 |
4
| Fitzpatrick Mark J. (CFO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Sold 200 shares
@ $73.0125, valued at
$14.6k
Sold 200 shares
@ $74.43, valued at
$14.9k
Sold 200 shares
@ $76.14, valued at
$15.2k
Sold 622 shares
@ $78.3849, valued at
$48.8k
Sold 4,478 shares
@ $79.3434, valued at
$355.3k
Sold 1,800 shares
@ $80.0317, valued at
$144.1k
Exercised 7,500 options to buy
@ $17.64, valued at
$132.3k
Exercised 2,850 options to buy
@ $17.64, valued at
$50.3k
|
|
| 08/28/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/26/2012 |
4
| Fitzpatrick Mark J. (CFO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Bought 200 shares
@ $14.159, valued at
$2.8k
Bought 300 shares
@ $14.148, valued at
$4.2k
|
|
| 06/03/2011 |
4
| Fitzpatrick Mark J. (CFO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Granted 220,000 options to buy
@ $17.64, valued at
$3.9M
|
|
|
|